Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses,...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is of fair value on EV/EBITDA, undervalue
Target Price
The average target price of BICO.ST is 29 and suggests 71% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell